Cargando…

Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is the fastest-growing liver disease in the world. Despite targeted agents which are needed to provide permanent benefits for patients with NAFLD, no drugs have been approved to treat NASH. Thyroid hormone is an important signaling molecule to maintain norma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Man, Xie, Huazhong, Shan, Hao, Zheng, Zhihua, Li, Guofeng, Li, Min, Hong, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835192/ https://www.ncbi.nlm.nih.gov/pubmed/35163026 http://dx.doi.org/10.3390/ijms23031102

Ejemplares similares

Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease
por: Kowalik, Marta A., et al.
Publicado: (2018)

Thyroid Hormones and Thyromimetics: A New Approach to Nonalcoholic Steatohepatitis?
por: Sinha, Rohit A., et al.
Publicado: (2020)

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis
por: Caddeo, Andrea, et al.
Publicado: (2023)

Thyromimetics: What does the future hold?
por: Unnikrishnan, A. G., et al.
Publicado: (2012)

Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196
por: Hönes, Georg Sebastian, et al.
Publicado: (2022)

Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2021)

The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice
por: Tancevski, Ivan, et al.
Publicado: (2010)

Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease
por: Fröhlich, Eleonore, et al.
Publicado: (2022)

Thyroid Hormone Levels in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease
por: Torun, Emel, et al.
Publicado: (2014)

Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease
por: Tahara, Kazuki, et al.
Publicado: (2019)

Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
por: Liao, Chia-Jung, et al.
Publicado: (2022)

Conferring liver selectivity to a thyromimetic using a novel nanoparticle increases therapeutic efficacy in a diet-induced obesity animal model
por: Wu, Ruiling, et al.
Publicado: (2023)

Association between Thyroid Hormones and Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis in Obese Individuals Undergoing Bariatric Surgery
por: Ashraf Ganjooei, Narges, et al.
Publicado: (2022)

Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver
por: Yao, Xuan, et al.
Publicado: (2014)

Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients
por: Wang, Bairong, et al.
Publicado: (2021)

Association Between Thyroid Hormone Levels and Advanced Liver Fibrosis in Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
por: Du, Jing, et al.
Publicado: (2021)

Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma
por: Xiao, Renyi, et al.
Publicado: (2023)

Thyroid Function in Obese Children with Non-Alcoholic Fatty Liver Disease
por: Bilgin, Hüseyin, et al.
Publicado: (2014)

Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics
por: Runfola, Massimiliano, et al.
Publicado: (2020)

Maternal Administration of the CNS-Selective Sobetirome Prodrug Sob-AM2 Exerts Thyromimetic Effects in Murine MCT8-Deficient Fetuses
por: Valcárcel-Hernández, Víctor, et al.
Publicado: (2023)

Evaluation of thyroid function and thyroid autoimmune disease in patients with non-alcoholic fatty liver disease
por: Naguib, Rania, et al.
Publicado: (2021)

Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study
por: Almomani, Ashraf, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
por: Arefhosseini, Sara, et al.
Publicado: (2022)

Correlation between the thyroid hormone levels and nonalcoholic fatty liver disease in type 2 diabetic patients with normal thyroid function
por: Zhang, Yuanyuan, et al.
Publicado: (2022)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes
por: Zhang, Min, et al.
Publicado: (2019)

Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease
por: Li, Ping, et al.
Publicado: (2022)

Alcohol Induces More Severe Fatty Liver Disease by Influencing Cholesterol Metabolism
por: Li, Bo, et al.
Publicado: (2019)

Coexistence of resistance to thyroid hormone and ectopic thyroid: ten-year follow-up
por: Guo, Man-Li, et al.
Publicado: (2016)

Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases
por: Tang, Qianyu, et al.
Publicado: (2022)

Screening strategy for non-alcoholic fatty liver disease
por: Zhang, Saisai, et al.
Publicado: (2023)

Low–Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Zuarth-Vázquez, Julia, et al.
Publicado: (2023)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease
por: Xie, Qi, et al.
Publicado: (2022)

Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration
por: Kim, Sung Eun, et al.
Publicado: (2023)

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease
por: Zeng, Minghui, et al.
Publicado: (2023)

Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
por: Song, Myeong Jun, et al.
Publicado: (2022)

The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)
por: D'Ambrosio, Roberta, et al.
Publicado: (2021)

Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia
por: Ho, Joon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t4pea1vuanh8vjbdbduc2rht7b